2-(10-hydroxyimidazo[2,1-a]isoquinolin-2-yl)imidazo[2,1-a]isoquinolin-10-ol;2-[2-[5-(2-hydroxyphenyl)-4,4-dimethylimidazol-2-yl]-5,5-dimethylimidazol-4-yl]phenol;2-[4-[2-(2-hydroxyphenyl)-1-phenylimidazol-4-yl]-1-phenylimidazol-2-yl]phenol;2-[2-(2-hydroxyphenyl)pyrazino[2,3-f]quinoxalin-9-yl]phenol;2-[6-[6-(2-hydroxyphenyl)pyrazin-2-yl]pyrazin-2-yl]phenol;2-[2-(2-hydroxyphenyl)-3,3,6,6-tetramethylpyrrolo[3,2-g]indol-7-yl]phenol;2-[4-[4-(2-hydroxyphenyl)-1,3,5-triazin-2-yl]-1,3,5-triazin-2-yl]phenol;platinum

C160H122N28O14Pt7 — CID 157273600

About 2-(10-hydroxyimidazo[2,1-a]isoquinolin-2-yl)imidazo[2,1-a]isoquinolin-10-ol;2-[2-[5-(2-hydroxyphenyl)-4,4-dimethylimidazol-2-yl]-5,5-dimethylimidazol-4-yl]phenol;2-[4-[2-(2-hydroxyphenyl)-1-phenylimidazol-4-yl]-1-phenylimidazol-2-yl]phenol;2-[2-(2-hydroxyphenyl)pyrazino[2,3-f]quinoxalin-9-yl]phenol;2-[6-[6-(2-hydroxyphenyl)pyrazin-2-yl]pyrazin-2-yl]phenol;2-[2-(2-hydroxyphenyl)-3,3,6,6-tetramethylpyrrolo[3,2-g]indol-7-yl]phenol;2-[4-[4-(2-hydroxyphenyl)-1,3,5-triazin-2-yl]-1,3,5-triazin-2-yl]phenol;platinum

2-(10-hydroxyimidazo[2,1-a]isoquinolin-2-yl)imidazo[2,1-a]isoquinolin-10-ol;2-[2-[5-(2-hydroxyphenyl)-4,4-dimethylimidazol-2-yl]-5,5-dimethylimidazol-4-yl]phenol;2-[4-[2-(2-hydroxyphenyl)-1-phenylimidazol-4-yl]-1-phenylimidazol-2-yl]phenol;2-[2-(2-hydroxyphenyl)pyrazino[2,3-f]quinoxalin-9-yl]phenol;2-[6-[6-(2-hydroxyphenyl)pyrazin-2-yl]pyrazin-2-yl]phenol;2-[2-(2-hydroxyphenyl)-3,3,6,6-tetramethylpyrrolo[3,2-g]indol-7-yl]phenol;2-[4-[4-(2-hydroxyphenyl)-1,3,5-triazin-2-yl]-1,3,5-triazin-2-yl]phenol;platinum (PubChem CID 157273600) has the molecular formula C160H122N28O14Pt7 and a molecular weight of 4026.46 g/mol. Its IUPAC name is 2-(10-hydroxyimidazo[2,1-a]isoquinolin-2-yl)imidazo[2,1-a]isoquinolin-10-ol;2-[2-[5-(2-hydroxyphenyl)-4,4-dimethylimidazol-2-yl]-5,5-dimethylimidazol-4-yl]phenol;2-[4-[2-(2-hydroxyphenyl)-1-phenylimidazol-4-yl]-1-phenylimidazol-2-yl]phenol;2-[2-(2-hydroxyphenyl)pyrazino[2,3-f]quinoxalin-9-yl]phenol;2-[6-[6-(2-hydroxyphenyl)pyrazin-2-yl]pyrazin-2-yl]phenol;2-[2-(2-hydroxyphenyl)-3,3,6,6-tetramethylpyrrolo[3,2-g]indol-7-yl]phenol;2-[4-[4-(2-hydroxyphenyl)-1,3,5-triazin-2-yl]-1,3,5-triazin-2-yl]phenol;platinum.

Molecular Properties

• Compound Name: 2-(10-hydroxyimidazo[2,1-a]isoquinolin-2-yl)imidazo[2,1-a]isoquinolin-10-ol;2-[2-[5-(2-hydroxyphenyl)-4,4-dimethylimidazol-2-yl]-5,5-dimethylimidazol-4-yl]phenol;2-[4-[2-(2-hydroxyphenyl)-1-phenylimidazol-4-yl]-1-phenylimidazol-2-yl]phenol;2-[2-(2-hydroxyphenyl)pyrazino[2,3-f]quinoxalin-9-yl]phenol;2-[6-[6-(2-hydroxyphenyl)pyrazin-2-yl]pyrazin-2-yl]phenol;2-[2-(2-hydroxyphenyl)-3,3,6,6-tetramethylpyrrolo[3,2-g]indol-7-yl]phenol;2-[4-[4-(2-hydroxyphenyl)-1,3,5-triazin-2-yl]-1,3,5-triazin-2-yl]phenol;platinum
• PubChem CID: 157273600
• Molecular Formula: C160H122N28O14Pt7
• Molecular Weight: 4026.46 g/mol
• Exact Mass: 4023.72
• IUPAC Name: 2-(10-hydroxyimidazo[2,1-a]isoquinolin-2-yl)imidazo[2,1-a]isoquinolin-10-ol;2-[2-[5-(2-hydroxyphenyl)-4,4-dimethylimidazol-2-yl]-5,5-dimethylimidazol-4-yl]phenol;2-[4-[2-(2-hydroxyphenyl)-1-phenylimidazol-4-yl]-1-phenylimidazol-2-yl]phenol;2-[2-(2-hydroxyphenyl)pyrazino[2,3-f]quinoxalin-9-yl]phenol;2-[6-[6-(2-hydroxyphenyl)pyrazin-2-yl]pyrazin-2-yl]phenol;2-[2-(2-hydroxyphenyl)-3,3,6,6-tetramethylpyrrolo[3,2-g]indol-7-yl]phenol;2-[4-[4-(2-hydroxyphenyl)-1,3,5-triazin-2-yl]-1,3,5-triazin-2-yl]phenol;platinum
• SMILES: CC1(C)C(c2ccccc2O)=Nc2c1ccc1c2N=C(c2ccccc2O)C1(C)C.CC1(C)N=C(C2=NC(C)(C)C(c3ccccc3O)=N2)N=C1c1ccccc1O.Oc1cccc2ccn3cc(-c4cn5ccc6cccc(O)c6c5n4)nc3c12.Oc1ccccc1-c1cnc2ccc3ncc(-c4ccccc4O)nc3c2n1.Oc1ccccc1-c1cncc(-c2cncc(-c3ccccc3O)n2)n1.Oc1ccccc1-c1nc(-c2cn(-c3ccccc3)c(-c3ccccc3O)n2)cn1-c1ccccc1.Oc1ccccc1-c1ncnc(-c2ncnc(-c3ccccc3O)n2)n1.[Pt].[Pt].[Pt].[Pt].[Pt].[Pt].[Pt]
• InChI: InChI=1S/C30H22N4O2.C26H24N2O2.2C22H14N4O2.C22H22N4O2.C20H14N4O2.C18H12N6O2.7Pt/c35-27-17-9-7-15-23(27)29-31-25(19-33(29)21-11-3-1-4-12-21)26-20-34(22-13-5-2-6-14-22)30(32-26)24-16-8-10-18-28(24)36;1-25(2)17-13-14-18-22(21(17)27-23(25)15-9-5-7-11-19(15)29)28-24(26(18,3)4)16-10-6-8-12-20(16)30;27-17-5-1-3-13-7-9-25-11-15(23-21(25)19(13)17)16-12-26-10-8-14-4-2-6-18(28)20(14)22(26)24-16;27-19-7-3-1-5-13(19)17-11-23-15-9-10-16-22(21(15)25-17)26-18(12-24-16)14-6-2-4-8-20(14)28;1-21(2)17(13-9-5-7-11-15(13)27)23-19(25-21)20-24-18(22(3,4)26-20)14-10-6-8-12-16(14)28;25-19-7-3-1-5-13(19)15-9-21-11-17(23-15)18-12-22-10-16(24-18)14-6-2-4-8-20(14)26;25-13-7-3-1-5-11(13)15-19-9-21-17(23-15)18-22-10-20-16(24-18)12-6-2-4-8-14(12)26;;;;;;;/h1-20,35-36H;5-14,29-30H,1-4H3;2*1-12,27-28H;5-12,27-28H,1-4H3;1-12,25-26H;1-10,25-26H
• InChIKey: QNONEOUHTILAJT-UHFFFAOYSA-N
• XLogP: 30.96
• TPSA: 608.08 Ų
• H-Bond Donors: 14
• H-Bond Acceptors: 42
• Rotatable Bonds: 19
• Heavy Atoms: 209
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	4026.46
LogP ≤ 5	30.96
H-Bond Donors ≤ 5	14
H-Bond Acceptors ≤ 10	42

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'Polycyclic_aromatic_hydrocarbon_3', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 2-(10-hydroxyimidazo[2,1-a]isoquinolin-2-yl)imidazo[2,1-a]isoquinolin-10-ol;2-[2-[5-(2-hydroxyphenyl)-4,4-dimethylimidazol-2-yl]-5,5-dimethylimidazol-4-yl]phenol;2-[4-[2-(2-hydroxyphenyl)-1-phenylimidazol-4-yl]-1-phenylimidazol-2-yl]phenol;2-[2-(2-hydroxyphenyl)pyrazino[2,3-f]quinoxalin-9-yl]phenol;2-[6-[6-(2-hydroxyphenyl)pyrazin-2-yl]pyrazin-2-yl]phenol;2-[2-(2-hydroxyphenyl)-3,3,6,6-tetramethylpyrrolo[3,2-g]indol-7-yl]phenol;2-[4-[4-(2-hydroxyphenyl)-1,3,5-triazin-2-yl]-1,3,5-triazin-2-yl]phenol;platinum?

The IUPAC name of 2-(10-hydroxyimidazo[2,1-a]isoquinolin-2-yl)imidazo[2,1-a]isoquinolin-10-ol;2-[2-[5-(2-hydroxyphenyl)-4,4-dimethylimidazol-2-yl]-5,5-dimethylimidazol-4-yl]phenol;2-[4-[2-(2-hydroxyphenyl)-1-phenylimidazol-4-yl]-1-phenylimidazol-2-yl]phenol;2-[2-(2-hydroxyphenyl)pyrazino[2,3-f]quinoxalin-9-yl]phenol;2-[6-[6-(2-hydroxyphenyl)pyrazin-2-yl]pyrazin-2-yl]phenol;2-[2-(2-hydroxyphenyl)-3,3,6,6-tetramethylpyrrolo[3,2-g]indol-7-yl]phenol;2-[4-[4-(2-hydroxyphenyl)-1,3,5-triazin-2-yl]-1,3,5-triazin-2-yl]phenol;platinum (CID 157273600) is 2-(10-hydroxyimidazo[2,1-a]isoquinolin-2-yl)imidazo[2,1-a]isoquinolin-10-ol;2-[2-[5-(2-hydroxyphenyl)-4,4-dimethylimidazol-2-yl]-5,5-dimethylimidazol-4-yl]phenol;2-[4-[2-(2-hydroxyphenyl)-1-phenylimidazol-4-yl]-1-phenylimidazol-2-yl]phenol;2-[2-(2-hydroxyphenyl)pyrazino[2,3-f]quinoxalin-9-yl]phenol;2-[6-[6-(2-hydroxyphenyl)pyrazin-2-yl]pyrazin-2-yl]phenol;2-[2-(2-hydroxyphenyl)-3,3,6,6-tetramethylpyrrolo[3,2-g]indol-7-yl]phenol;2-[4-[4-(2-hydroxyphenyl)-1,3,5-triazin-2-yl]-1,3,5-triazin-2-yl]phenol;platinum.

What is the SMILES notation for 2-(10-hydroxyimidazo[2,1-a]isoquinolin-2-yl)imidazo[2,1-a]isoquinolin-10-ol;2-[2-[5-(2-hydroxyphenyl)-4,4-dimethylimidazol-2-yl]-5,5-dimethylimidazol-4-yl]phenol;2-[4-[2-(2-hydroxyphenyl)-1-phenylimidazol-4-yl]-1-phenylimidazol-2-yl]phenol;2-[2-(2-hydroxyphenyl)pyrazino[2,3-f]quinoxalin-9-yl]phenol;2-[6-[6-(2-hydroxyphenyl)pyrazin-2-yl]pyrazin-2-yl]phenol;2-[2-(2-hydroxyphenyl)-3,3,6,6-tetramethylpyrrolo[3,2-g]indol-7-yl]phenol;2-[4-[4-(2-hydroxyphenyl)-1,3,5-triazin-2-yl]-1,3,5-triazin-2-yl]phenol;platinum?

The canonical SMILES for 2-(10-hydroxyimidazo[2,1-a]isoquinolin-2-yl)imidazo[2,1-a]isoquinolin-10-ol;2-[2-[5-(2-hydroxyphenyl)-4,4-dimethylimidazol-2-yl]-5,5-dimethylimidazol-4-yl]phenol;2-[4-[2-(2-hydroxyphenyl)-1-phenylimidazol-4-yl]-1-phenylimidazol-2-yl]phenol;2-[2-(2-hydroxyphenyl)pyrazino[2,3-f]quinoxalin-9-yl]phenol;2-[6-[6-(2-hydroxyphenyl)pyrazin-2-yl]pyrazin-2-yl]phenol;2-[2-(2-hydroxyphenyl)-3,3,6,6-tetramethylpyrrolo[3,2-g]indol-7-yl]phenol;2-[4-[4-(2-hydroxyphenyl)-1,3,5-triazin-2-yl]-1,3,5-triazin-2-yl]phenol;platinum is CC1(C)C(c2ccccc2O)=Nc2c1ccc1c2N=C(c2ccccc2O)C1(C)C.CC1(C)N=C(C2=NC(C)(C)C(c3ccccc3O)=N2)N=C1c1ccccc1O.Oc1cccc2ccn3cc(-c4cn5ccc6cccc(O)c6c5n4)nc3c12.Oc1ccccc1-c1cnc2ccc3ncc(-c4ccccc4O)nc3c2n1.Oc1ccccc1-c1cncc(-c2cncc(-c3ccccc3O)n2)n1.Oc1ccccc1-c1nc(-c2cn(-c3ccccc3)c(-c3ccccc3O)n2)cn1-c1ccccc1.Oc1ccccc1-c1ncnc(-c2ncnc(-c3ccccc3O)n2)n1.[Pt].[Pt].[Pt].[Pt].[Pt].[Pt].[Pt].

What is the InChIKey of 2-(10-hydroxyimidazo[2,1-a]isoquinolin-2-yl)imidazo[2,1-a]isoquinolin-10-ol;2-[2-[5-(2-hydroxyphenyl)-4,4-dimethylimidazol-2-yl]-5,5-dimethylimidazol-4-yl]phenol;2-[4-[2-(2-hydroxyphenyl)-1-phenylimidazol-4-yl]-1-phenylimidazol-2-yl]phenol;2-[2-(2-hydroxyphenyl)pyrazino[2,3-f]quinoxalin-9-yl]phenol;2-[6-[6-(2-hydroxyphenyl)pyrazin-2-yl]pyrazin-2-yl]phenol;2-[2-(2-hydroxyphenyl)-3,3,6,6-tetramethylpyrrolo[3,2-g]indol-7-yl]phenol;2-[4-[4-(2-hydroxyphenyl)-1,3,5-triazin-2-yl]-1,3,5-triazin-2-yl]phenol;platinum?

The InChIKey is QNONEOUHTILAJT-UHFFFAOYSA-N. The full InChI is InChI=1S/C30H22N4O2.C26H24N2O2.2C22H14N4O2.C22H22N4O2.C20H14N4O2.C18H12N6O2.7Pt/c35-27-17-9-7-15-23(27)29-31-25(19-33(29)21-11-3-1-4-12-21)26-20-34(22-13-5-2-6-14-22)30(32-26)24-16-8-10-18-28(24)36;1-25(2)17-13-14-18-22(21(17)27-23(25)15-9-5-7-11-19(15)29)28-24(26(18,3)4)16-10-6-8-12-20(16)30;27-17-5-1-3-13-7-9-25-11-15(23-21(25)19(13)17)16-12-26-10-8-14-4-2-6-18(28)20(14)22(26)24-16;27-19-7-3-1-5-13(19)17-11-23-15-9-10-16-22(21(15)25-17)26-18(12-24-16)14-6-2-4-8-20(14)28;1-21(2)17(13-9-5-7-11-15(13)27)23-19(25-21)20-24-18(22(3,4)26-20)14-10-6-8-12-16(14)28;25-19-7-3-1-5-13(19)15-9-21-11-17(23-15)18-12-22-10-16(24-18)14-6-2-4-8-20(14)26;25-13-7-3-1-5-11(13)15-19-9-21-17(23-15)18-22-10-20-16(24-18)12-6-2-4-8-14(12)26;;;;;;;/h1-20,35-36H;5-14,29-30H,1-4H3;2*1-12,27-28H;5-12,27-28H,1-4H3;1-12,25-26H;1-10,25-26H;;;;;;;.

What are the key properties of 2-(10-hydroxyimidazo[2,1-a]isoquinolin-2-yl)imidazo[2,1-a]isoquinolin-10-ol;2-[2-[5-(2-hydroxyphenyl)-4,4-dimethylimidazol-2-yl]-5,5-dimethylimidazol-4-yl]phenol;2-[4-[2-(2-hydroxyphenyl)-1-phenylimidazol-4-yl]-1-phenylimidazol-2-yl]phenol;2-[2-(2-hydroxyphenyl)pyrazino[2,3-f]quinoxalin-9-yl]phenol;2-[6-[6-(2-hydroxyphenyl)pyrazin-2-yl]pyrazin-2-yl]phenol;2-[2-(2-hydroxyphenyl)-3,3,6,6-tetramethylpyrrolo[3,2-g]indol-7-yl]phenol;2-[4-[4-(2-hydroxyphenyl)-1,3,5-triazin-2-yl]-1,3,5-triazin-2-yl]phenol;platinum?

2-(10-hydroxyimidazo[2,1-a]isoquinolin-2-yl)imidazo[2,1-a]isoquinolin-10-ol;2-[2-[5-(2-hydroxyphenyl)-4,4-dimethylimidazol-2-yl]-5,5-dimethylimidazol-4-yl]phenol;2-[4-[2-(2-hydroxyphenyl)-1-phenylimidazol-4-yl]-1-phenylimidazol-2-yl]phenol;2-[2-(2-hydroxyphenyl)pyrazino[2,3-f]quinoxalin-9-yl]phenol;2-[6-[6-(2-hydroxyphenyl)pyrazin-2-yl]pyrazin-2-yl]phenol;2-[2-(2-hydroxyphenyl)-3,3,6,6-tetramethylpyrrolo[3,2-g]indol-7-yl]phenol;2-[4-[4-(2-hydroxyphenyl)-1,3,5-triazin-2-yl]-1,3,5-triazin-2-yl]phenol;platinum has a molecular weight of 4026.46 g/mol, XLogP of 30.96, 19 rotatable bonds, 14 hydrogen bond donors, and 42 hydrogen bond acceptors.

Where does this data come from?

All data for 2-(10-hydroxyimidazo[2,1-a]isoquinolin-2-yl)imidazo[2,1-a]isoquinolin-10-ol;2-[2-[5-(2-hydroxyphenyl)-4,4-dimethylimidazol-2-yl]-5,5-dimethylimidazol-4-yl]phenol;2-[4-[2-(2-hydroxyphenyl)-1-phenylimidazol-4-yl]-1-phenylimidazol-2-yl]phenol;2-[2-(2-hydroxyphenyl)pyrazino[2,3-f]quinoxalin-9-yl]phenol;2-[6-[6-(2-hydroxyphenyl)pyrazin-2-yl]pyrazin-2-yl]phenol;2-[2-(2-hydroxyphenyl)-3,3,6,6-tetramethylpyrrolo[3,2-g]indol-7-yl]phenol;2-[4-[4-(2-hydroxyphenyl)-1,3,5-triazin-2-yl]-1,3,5-triazin-2-yl]phenol;platinum is sourced from PubChem (CID 157273600), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).